Leidos Holdings, US5253271028

Leidos Holdings stock at 126.15 euros as fair value is trimmed

Published on 10/30/2026 at 01:36 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Leidos Holdings stock is quoted at 126.15 euros after analysts lowered valuation estimates. Health-sector uncertainty remains a key concern.

Analysten bleiben bei Leidos vorsichtig

  • Eine Analyse vom 17. Oktober beziffert die gesenkte Fair-Value-Schätzung auf 151,73 US-Dollar je Aktie.
  • Als Belastungsfaktor gilt insbesondere die Unsicherheit im Health-Segment, während Verteidigung und digitale Geschäftsbereiche stützen.
  • Leidos will seine Zahlen für das dritte Quartal am 3. November 2026 vorlegen.
Leidos Holdings, US5253271028, Illustration mit AI erstellt.

Analyst views on Leidos Holdings have become more cautious ahead of the company's third-quarter report. In an analysis published on October 17, Yahoo Finance reported that the fair-value estimate had been reduced from 157.73 US dollars to 151.73 US dollars per share.

Health business weighs on valuation

The analysis linked the more cautious view to uncertainty around Leidos' Health segment. It also noted that the company's defense, intelligence, digital and homeland portfolios continue to support the investment case, while analysts debate the balance between those areas and pressure in Health.

JPMorgan had cut its target to 142 US dollars from 160 US dollars and downgraded the stock to Neutral, according to the cited analysis. It added that Jefferies, TD Cowen, Goldman Sachs and Citi had also trimmed targets in recent months, with Health revenue and margin assumptions a recurring concern.

Quote ahead of quarterly results

Lang & Schwarz quoted Leidos Holdings at 126.15 euros on October 29, 2026, at 22:59:30 Berlin time. The available quote is a dated market snapshot; no Xetra comparison is included here. Investors may therefore use the level as a reference point, but should distinguish the euro quote from the analyst targets expressed in US dollars.

Leidos is scheduled to report its third-quarter 2026 results on November 3, 2026. The upcoming release may provide more information about the Health segment and whether strength in defense-related activities is offsetting pressure elsewhere. The reported valuation figures remain analyst estimates rather than company guidance.

Leidos Holdings stock at a glance

  • Company: Leidos Holdings, Inc.
  • ISIN: US5253271028
  • Ticker: LDOS
  • Home exchange: NYSE
  • Lang & Schwarz quote: 126.15 euros on October 29, 2026, at 22:59:30 Berlin time
  • Analyst fair-value estimate: 151.73 US dollars per share, according to the October 17 analysis

Investors can follow the real-time quote of Leidos Holdings stock separately from the valuation discussion.

Broader sentiment remains relevant for US technology and defense-related shares; see Current market reports.

More company-specific developments are collected under More news and analyses on Leidos Holdings stock.

Disclaimer...
en | US5253271028 | LEIDOS HOLDINGS | boerse | 70431446 |